Study examines use of diagnostic tests in adolescents with hypertension

July 23, 2012

CHICAGO - A study of adolescents with hypertension enrolled in the Michigan Medicaid program suggests that guideline-recommended diagnostic tests - echocardiograms and renal ultrasonography - were poorly used, according to a report published Online First by Archives of Pediatrics & Adolescent Medicine, a JAMA Network publication.

Hypertension is a growing problem for adolescents because of the association between obesity and hypertension. Current pediatric guidelines recommend laboratory tests and renal ultrasonography for all pediatric patients with hypertension to rule out renal (kidney) disease. The guidelines also recommend echocardiograms to assess target organ damage. But little is known about echocardiogram use among adolescents in comparison with other recommended diagnostic tests (renal ultrasonography) and nonrecommended, but more readily available tests, such as electrocardiograms (EKGs), according to the study background.

Esther Y. Yoon, M.D., M.P.H., and colleagues of the University of Michigan, Ann Arbor, examined echocardiogram use in adolescents and compared it with EKG and renal ultrasonography use in an analysis of administrative claims data from the Michigan Medicaid program from 2003 to 2008.

There were 951 adolescents with "essential" hypertension (i.e., the cause is unknown) who had antihypertensive pharmacy claims: 24 percent (226) had echocardiograms; 22 percent (207) had renal ultrasonography; and 50 percent (478) had EKGs, the results indicate.

"Our study describes for the first time, to our knowledge, equally low levels of obtaining echocardiograms and renal ultrasonography, which are recommended by national hypertension guidelines, by adolescents with essential hypertension," the authors note. "In contrast, we found that one-half of adolescents with essential hypertension had at least one EKG during the study period, a diagnostic test that is not recommended by pediatric hypertension guidelines but one that is recommended for adults with hypertension."

Boys, younger adolescents, those who had EKGs and those who had renal ultrasonography were more likely to receive echocardiograms compared with girls, older adolescents, and those who did not have EKGs or renal ultrasonography.

The authors suggest that the patterns of EKG and echocardiogram use in their study raises questions "about the level of familiarity, awareness or agreement with pediatric hypertension guideline recommendations and the rationale behind these recommendations."

"The decision and choice of diagnostic tests to evaluate for target organ damage in adolescents with essential hypertension warrant further study to understand the underlying rationale for those decisions and to determine treatment effectiveness," the researchers conclude.

(Arch Pediatr Adolesc Med. Published online July 23, 2012. doi:10.1001/archpediatrics.2012.1173. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: The study was funded by a grant from the National Heart, Lung and Blood Institute. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Editorial: More Questions than Answers About Hypertension in Youths

In an editorial, Sarah D. de Ferranti, M.D., M.P.H., of Boston Children's Hospital, and Matthew W. Gillman, M.D., S.M., of Harvard Medical School, Boston, write: "The answers to the many questions raised here are unclear, pointing to the need for more information about the extent to which the BP [blood pressure] guidelines overall, and recommended diagnostic testing in particular, are implemented."

"It is important to get these answers," they continue.

"Future revision of the guidelines will require not only updating the evidence base for what should be done in ideal circumstances, but also what can be done in the real world given the range of possible health care provider, patient and payor facilitators and barriers to implementation," they conclude.

(Arch Pediatr Adolesc Med. Published online July 23, 2012. doi:10.1001/archpediatrics.2012.1503. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: The authors made financial disclosures. Also, de Ferranti's work is supported by grants from the National Institutes of Health and funding from the Boston Children's Heart Foundation. Gillman's work is funded in part by a grant from the National Heart, Lung and Blood Institute. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
-end-
To contact Esther Y. Yoon, M.D., M.P.H., call Mary Masson at 734-764-2220 or email mfmasson@med.umich.edu. To reach editorial author Sarah D. de Ferranti, M.D., M.P.H., call Keri Stedman at 617-919-3110 or email keri.stedman@childrens.harvard.edu.

The JAMA Network Journals

Related Hypertension Articles from Brightsurf:

Risk of target organ damage in patients with masked hypertension versus sustained hypertension
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.1261, Yue Wu, Guoyue Zhang, Rong Hu and Jianlin Du from The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China consider the risk of target organ damage in patients with masked hypertension versus sustained hypertension.

Overactive enzyme causes hereditary hypertension
After more than 40 years, several teams at the MDC and ECRC have now made a breakthrough discovery with the help of two animal models: they have proven that an altered gene encoding the enzyme PDE3A causes an inherited form of high blood pressure.

Diagnosing hypertension in children
Study results call into question the utility of testing blood pressure load--the proportion of elevated blood pressure readings detected over 24 hours--for diagnosing hypertension in children.

When the best treatment for hypertension is to wait
A new study concluded that a physician's decision not to intensify hypertension treatment is often a contextually appropriate choice.

Treatment of hypertension induced albuminuria
Patients with albuminuria will usually need more than one drug to achieve blood pressure control, particularly if the aim is also to reduce albuminuria.

Diagnosing and treating resistant hypertension
Resistant blood pressure affects 12 percent to 15 percent of people currently being treated for high blood pressure.

Dementia can be caused by hypertension
A new study in Cardiovascular Research indicates that patients with high blood pressure are at a higher risk of developing dementia.

Hormone imbalance causes treatment-resistant hypertension
British researchers have discovered a hormone imbalance that explains why it is very difficult to control blood pressure in around 10 per cent of hypertension patients.

Breastfeeding reduces hypertension risk
A study published in the American Journal of Hypertension indicates that women who breastfeed more children, and for longer periods of time, are less likely to suffer from hypertension after they reach menopause.

Lung cancer triggers pulmonary hypertension
Nearly half of all advanced-stage lung cancer patients develop arterial pulmonary hypertension.

Read More: Hypertension News and Hypertension Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.